Seed · Biotech · Galway, Ireland · Founded 2019 · 5–10 employees
Relevium Medical is an Irish spin‑out from the University of Galway’s BioInnovate programme, developing hydrogel‑based therapeutics for chronic pain conditions such as knee osteoarthritis. The company has secured a substantial €4.6 million government grant in late 2024 to advance its RestOAre project, a promising signal of traction. Its senior leadership includes experienced pharmaceutical executives and strong academic ties, exemplifying a well‑connected interdisciplinary team. The development of an injectable hydrogel platform that offers longer‑lasting pain relief than current treatments, supported by preclinical success, underscores its potential in a multibillion‑euro pain management market.
No open roles listed right now.